Andropause: Endocrinology, erectile dysfunction, and prostate pathophysiology

Archives of Andrology

Volumn 50, Issue 2, 2004, Pages 45-68

  Hafez, B ^a   Hafez, E S E ^a  

^a Reproductive Health Center   (United States)

Author keywords

Andropause; Endocrinology; Osteoporosis; Pathophysiology; Prostate

Indexed keywords

ALPROTADIL; ANDROGEN; APOMORPHINE; CALCIUM; FLUOXYMESTERONE; GROWTH HORMONE; HEPTANOIC ACID DERIVATIVE; METHYLTESTOSTERONE; PAPAVERINE; PHENTOLAMINE; PHENTOLAMINE MESYLATE; PROSTAGLANDIN E1; SILDENAFIL; TESAMONE; TESTANDRO; TESTOPEL; TESTOSTERONE; TESTOSTERONE PROPIONATE; UNCLASSIFIED DRUG; YOHIMBINE;

ANDROPAUSE; ANXIETY; BLADDER DYSFUNCTION; COMPARATIVE STUDY; DEVICE; DISEASE ASSOCIATION; DRUG APPROVAL; DRUG EFFICACY; DRUG SAFETY; ENDOCRINOLOGY; ERECTILE DYSFUNCTION; FRACTURE; GROWTH HORMONE DEFICIENCY; HEADACHE; HEART INFARCTION; HEART PALPITATION; HOT FLUSH; HUMAN; HYPERTENSION; MENOPAUSE; MOLECULAR MECHANICS; MUSCLE MASS; NONHUMAN; ORCHIECTOMY; OSTEOPENIA; OSTEOPOROSIS; PAIN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE DISEASE; PROSTATE HYPERTROPHY; PROSTATECTOMY; RETINA DISEASE; REVIEW; RISK FACTOR; SEXUAL INTERCOURSE; STOMACH PAIN; SUPPLEMENTATION; TREATMENT OUTCOME; TREMOR; URETHRA DISEASE; VISUAL DISORDER;

ANDROGENS; ANIMALS; CLIMACTERIC; HUMANS; IMPOTENCE; MALE; PROSTATIC NEOPLASMS;

EID: 80052646326     PISSN: 01485016     EISSN: None     Source Type: Journal    
DOI: 10.1080/01485010490274131     Document Type: Review

References (82)

1. Abrams PH (1979): Perfusion urethral profilometry. Urol Clin North Am 6:103-110.
2. Abrams PH, Farrar DJ, et al. (1979): The results of prostatectomy: a symptomatic and urodynamic analysis of 152 patients. Urol 121:640-642.
3. Althof SE, et al. (1999): EDITS:Development of questionnaires for evaluating satisfaction with treatments fore erectile dysfunction. Urology 53:793-799.
4. Andrew J, Nathan PW (1965): The cerebral control of micturition. Proc Soc Med 58:553-555.
5. Araujo AB, et al. (1998): The relationship between depressive symptoms and male erectile dysfunction: cross sectional results from the Massachusetts Male Aging Study. Psychosom Med 60:458-465.
6. Arnold EP (1974): Cystometry: postural effect in incontinent women. Urol Int 29:185-186.
7. Arver S, et al. (1996): Improvement of sexual function in testosterone deficient men treated for 1 year with a permeation-enhanced testosterone transdermal system. J Urol 155:1604-1608.
8. Behre HM, Bohmeyer J, Nieschlag E (1994): Prostate volume in testosterone-treated and untreated hypogonadal men in comparison to age-matched normal controls. Clin Endocrinol (Oxf) 40:341-349.
9. Breecher EM (1984); In: Love, Sex and Aging. Boston, MA: Little Brown.
10. Bremner WJ, Vitiello MV, Pronz PN (1983): Loss of circadian rhythmicity in blood testosterone levels with aging in normal men. J Clin Endocrinol Metab 56:1278-1281.
11. Brocklehurst JC, et al. (1977): Bacteriuria in geriatric hospital patients: its correlates and management. Age and Aging 6:240-254.
12. Burns Cox, Gingell C (1997): The andropause: fact or fiction? Postgrad Med J 863:553-556.
13. Buvat J, Lemaire A (1997): Endocrine screening in 1022 men with erectile dysfunction: clinical significance and cost effective strategy. J Urol 158:1764-1767.
14. Chamness SL, et al. (1995): The effect of androgen on nitric oxide synthase in the male reproductive tract of the rat. Fertil Steril 63:1101-1107.
15. Clopper RR, et al (1993): Psychosexual behavior in hypopituitary men: a controlled comparison of gonadotrophin and testosterone replacement. Psychoneuroendocrinology 18:149-161.
16. Cohn L, et al (1993): Carpal tunnel syndrome and gynaecomastia during growth hormone treatment of elderly men with low circulating IGF-I concentrations. Clin Endocrinol 39: 417-425.
17. Crooks R, Baur K (1996): In: Our Sexuality. Pacific Grove, CA: Brooks Cole.
18. Cunningham GR, et al (1990): Testosterone replacement and sleep-related erections in hypogonadal men. J Clin Endocrinol Metab 70:792-797.
19. Davidson JM, Kwean M, Greenleaf WJ (1982): Hormonal replacement and sexuality in men. Clin Endocrinol Metab 11:599-623.
20. Diver MJ, et al. (1997): Indices of androgen status in elderly men. British Geriatrics Society Annual Meeting Abstr. #110.
21. Edwards L, Malvern J (1974): The urethral pressure profile: theoretical considerations and clinical application. Br J. Urol 46:325-336.
22. Emmanuele AJ, et al. (1999): Lack of sexual activity from erectile dysfunction is associated with a reversible reduction in serum testosterone. Int J Androl 22:385-392.
23. Farrar DJ (1994): Urodynamics in the elderly, Chapter 23:Urodynamics: Principles, Practice and Application, edits A.R. Bar
24. Feldman HA, et al. (1994): Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study. J Urol 151:54-61.
25. Garban H, et al. (1995): Restoration of normal adult penile erectile response in aged rats by long-term treatment with androgen. Biol Reprod 53:1365-1372.
26. Gray A, et al. (1991): Age, disease and changing sex hormone levels in middle-aged men: results of the Massachusetts Male Aging Study. J Clin Endocrinol Metab 73:1016-1025.
27. Griffiths Jones, Abrams PA (1990): The stamey endoscopic bladder neck suspension in the elderly. 65:170-172.
28. Ham RJ, Sloane PD (1992): In: Primary Care Geriatrics, 2nd ed. St. Louis, IL: Mosby.
29. Heller CG, Myers G (1944): The male climacteric, its symptomatology, diagnosis and treatment. JAMA 126:472-477.
30. Hodson DS, Skeen R (1994): Sexuality and aging: the hammerlock of myths. Appl Gerontol 7: 219-235.
31. Jain P, Rademaker AW, McVary KT (2000): Testosterone supplementation for erectile dysfunction: results of a meta-analysis. J Urol 164:371-375.
32. Janowsky JS, Oviatt SK, Orwoll ES (1994): Testosterone influences spatial cognition in older men. Behav Neurosci 108:325-332.
33. Jenike M (1987): In: Geriatric Psychiatry & Psychopharmacology. New Haven, CT: Year Book.
34. Johnson AR, Jarrow JP (1992): Is routine endocrine testing of impotent men necessary? J Urol 147:1542-1543.
35. Kaiser FE, et al. (1988): Impotence and aging: clinical and hormonal factors. J Am Geriatr Soc 36:511-519.
36. Kaplan HS (1990): Sex, intimacy and the aging process. J Am Acad Psychoanal 18:185-205.
37. Kenney RA (1989): In: Physiology of Aging, 2nd ed. Chicago: Year Book.
38. Lue TF (2000): Erectile dysfunction. N Engl J Med 342:1802-1813.
39. Lugg J, Rajifer J (1996): Drug therapy for erectile dysfunction. AUA Update Series, 1996, Vol XV: Lesson 36, pp.290-295.
40. Marks, S (1999): Prostate Cancer: A Family Guide to Diagnosis, Treatment and Survival, rev. ed. Tucson, AZ: Fisher Books.
41. Matsumoto AM (1994): Hormonal therapy of male hypogonadism. Endocrinol Metab Clin North Am 33:857-875.
42. Miller TA (2000): Diagnostic evaluation of erectile dysfunction. Am Fam Physician 61:95-104.
43. Monga M, et al. (2002): Patient satisfaction with testosterone supplementation for the treatment of erectile dysfunction. Arch Androl 48:200-207.
44. Mooradian AD (1991): Geriatric sexuality and chronic diseases. Clin Geriat Med 28:113-131.
45. Morales A, et al. (1997): Testosterone supplementation for hypogonadal impotence: assessment of biochemical measures and therapeutic outcomes. J Urol 157:849-854.
46. Morales A, et al. (2000): Andropause: a misnomer for a a true clinical entity. J Clin Endocrinol Metab 163:705-712.
47. Morgastern S, Abrahams, A (1993): The Prostate Sourcebook: Everything You Need to Know 3rd ed. Los Angeles, CA: Lowell House.
48. Morley JE, et al. (1996): Potentially predictive and manipulable blood serum correlates of aging in the healthy human male: progressive decreases in bioavailable testosterone, dehydroepiandrosterone sulfate and the ratio of insulin-like growth factor 1 to growth hormone. Proc Natl Acad Sci USA 94:7537-7542.
49. Morley JE, Perry HM (1999): Androgen deficiency in aging men. Med Clin North Am 1279-1289.
50. Mundy TP, Stephenson HJ (1995): Erectile Dysfunction.
51. Ouslander J, et al. (1988): Simple versus multichannel cystometry in the evaluation of bladder function in an incontinenent geriatric population. J Urol 140:1482-1486.
52. Penson DF, et al. (1996): Androgen and pituitary control of penile nitric oxide synthase and erectile function in the rat. Biol Reprod 55:567-574.
53. Reilly CM, et al. (1997): Androgens modulate the alpha-adrenergic responsiveness of vascular smooth muscle in the corpus cavernosum. J Androl 18:26-31.
54. Reilly CM, et al. (1997): Androgenic regulation of NO availability in rat penile erection. J Androl 18:110-115.
55. Reilly CM, et al. (1997): Androgenic maintenance of the rat erectile response via a non-nitirc-oxide-dependent pathway. J Androl 18:588-594.
56. Rosen RC, et al. (1999): Development and evaluation of an abridged, 5-item version of the International Index of Erectile Function (HEF-5) as a diagnostic tool for erectile dysfunction. Int J Impot Res 11:319-326.
57. Rudman D, et al. (1990): Effects of human growth hormone in men over 60 years old. N Engl J Med 323:1-6.
58. Rudman D, Shetty KR (1994): Unanswered questions concerning the treatment of hyposomatotropism and hypogonadism in elderly men. J Am Geriat Soc. 42:522-527.
59. Rubinow DR, Schmidt PJ (1996): Androgens, brain and behavior. Am J Psychiatry 153:974-984.
60. Sadowsky M, et al. (1993): Sexual activity and sex hormone levels in aging men. Int Psychogeriatr 5:181-186.
61. Savine R, Sonksen PH (1999): Is the somatopause an indication for growth hormone? J Endocrinol Invest 22:142-149.
62. Schiavi RC, et al. (1993): Hormones and nocturnal tumesence in healthy aging men. Arch Sex Behav 22:207-215.
63. Schiar A, et al. (1997): Androgens modulate nitric oxide synthase messenger ribonucleic acid expression in neurons of the major pelvic ganglion in the rat. Endocrinology 138:3093-3102.
64. Shabsigh R (1997): The effects of testosterone on the cavernous tissue and erectile function World J Urol 15:21-26.
65. Shabsigh R, et al. (1998): Androgen induction of DNA synthesis in the rat penis. Urology 52:723-728.
66. Sequard B (1889): The effects on man by subcutaneous injections of a liquid obtained from the testicles of animals. Lancet 20:105-107.
67. Tan R (1997): Pathological fracture due to testosterone deficiency in an elderly man. Abst Annual Scientific Meeting of the Am Geriatr Soc.
68. Tan RS, Bransgrove LB (1997): Andropause: is there a role for hormone replacement therapy? Clin Geriatr 5:46-58.
69. Tan Rs, Bransgrove L (1998): Testosterone replacement therapy:what is its potential in elderly men? Postgrad Med 103:247-256.
70. Tan RS (1999): Managing the andropause in aging males. Clin Geriatr 7:63-67.
71. Tan RS, Philip P (1999): Perceptions of and risk factors for the andropause. Arch Androl 43:97-103.
72. Tenover JS (1992): Effects of testosterone supplementation in the aging male. J Clin Endocrinol Metab 75:1092-1098.
73. Thienhaus, OU (1988): Practical overview of sexual function and advancing age. Geriatrics 43:63-67.
74. Tsitouras PD, et al. (1982): Relationship of serum testosterone to sexual activity in healthy elderly men. J Gerontol 37:288-293.
75. VandenBerg TL, Hellstrom WJ (1997): Individualizing androgen replacement therapy. Contemp Urol 9:25-40.
76. Vermeulen A (1991): Clinical review 24: androgens in the aging male. J Clin Endocrinol Metab 73:221-224.
77. Vermeulen A (1993): The male climacterium. Ann Med 25:531-534.
78. Vermeulen A, et al. (1972): Testosterone secretion and metabolism in male senescence. J Clin Endocrinol Metab 34:730-735.
79. Walz, TH, Blum NS (1987): In: Sexual Health in Later Life. Lexington, MA: Lexington Books.
80. Wang, C, et al (2000): Transdermal testosterone gel improves sexual function, mood, muscle strength and body composition parameters in hypogonadal men. J Clin Endocrinol Metab 85:2839-2853.
81. Williams, ME (1995): In: The American Geriatrics Society's Complete Guide to Aging and Mental Health. New York:Random House.
82. Wilson WD, Roehrborn C (1999): Long term consequences of castration in men: Lessons from the Skoptzy and the Eunuchs of the Chinese and Ottoman Courts. J Clin Endocrinol Metab 84:4324-4331.